Related Experiment Video
Updated: Jun 30, 2026

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
[Evaluation of aortic atherosclerosis by transesophageal echocardiography. Prognostic implications]
A Cohen1, C Tzourio, P Amarenco
1Service de cardiologie, hôpital Saint-Antoine, Paris.
Insights
Aortic arch atherosclerosis, particularly plaques ≥4mm thick, significantly increases stroke risk. This condition is a key indicator of broader vascular disease and a source of embolisms.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Vascular Biology
Background:
- Atherosclerosis in the aortic arch is increasingly recognized as a source of cerebral infarction.
- Transesophageal echocardiography confirms atherothrombosis in the ascending aorta as a potential embolic source.
- Aortic plaque thickness is a critical factor in assessing stroke risk.
Purpose of the Study:
- To investigate the association between aortic arch plaque characteristics and the risk of cerebral infarction.
- To evaluate aortic plaque as a marker for overall vascular risk.
- To identify high-risk plaque features for improved patient management.
Main Methods:
- The French Study of Aortic Plaque in Stroke (FAPS) trial followed 331 patients over 60 with cerebral infarction for 2.4 years.
- Aortic plaque thickness (≥4mm) and morphology (thrombus, irregularity) were assessed.
- Incidence of cerebral infarction and cardiovascular events were recorded.
Main Results:
- Aortic plaques ≥4mm thick were associated with a 3.8-fold increased risk of cerebral infarction.
- These plaques also correlated with a 3.5-fold increased risk of cardiovascular complications.
- Plaque morphology, independent of thickness, influenced patient prognosis.
Conclusions:
- Atherosclerosis of the ascending aorta and aortic arch is a significant source of systemic embolism.
- This condition serves as a potent marker for generalized vascular risk.
- Defining high-risk plaques aids in evaluating therapies targeting the atherosclerotic process.
Abstract:
A recent anatomical study has reported a relationship between the presence of ulcerated atheromatous plaque of the aortic arch and cerebral infarction. Several studies using transoesophageal echocardiography have established that atherothrombosis of the ascending and proximal is a potential source of systemic embolism. We have shown that aortic plaques > or = 4 mm in thickness increase the risk of cerebral infarction by 9. Several studies have shown that this localisation of atherosclerosis was also a powerful marker of general vascular risk. In the multicenter FAPS (French Study of Aortic Plaque in Stroke) trial, the authors followed up 331 patients who had suffered cerebral infarction, aged over 60 years, for a mean duration of 2.4 years. The occurrence rate of cerebral infarction and the incidence of cardiovascular complications (death, myocardial infarction, cerebral infarction, systemic embolism) was respectively 11.9% and 26% per year. The presence of plaques with thickness greater or equal to 4 mm was associated with an adjusted relative risk of 3.8 (95% confidence interval, 1.8 to 7.8) and 3.5 (95% confidence interval, 3.1 to 5.9) respectively. The influence of plaque morphology (thrombus, irregularity, absence of calcification), independently of its thickness, also seems to affect the prognosis. In this study, as in those reported by other groups, the influence of anti-thrombotic therapy was not specifically addressed. The definition of high risk plaques (thickness, irregularity, thrombus) could be useful in the evaluation of therapy which affects the atherosclerotic process (antiplatelet agents, anticoagulants, statins). We conclude that atherosclerosis of the ascending aorta and aortic arch is a potential source of systemic embolism and a powerful marker of overall vascular risk.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies

